The future of cancer treatment lies in the development of personalized medicine. Advances in next-generation sequencing technologies enable comprehensive profiling of individual tumors to identify specific genetic alterations. This information can be used to tailor treatments to the unique genetic make-up of each patient’s cancer, enhancing the efficacy and reducing the side effects of therapy.
